Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Samsung Biologics has disclosed the setting of December 31, 2024, as the record date and the closure of its shareholder register (suspension of entry of alteration in the register) from January 1, 2025, to January 31, 2025, to determine entitled shareholders for its 14th Annual General Meeting (AGM).
📊 [Key Disclosure Details & Financial Figures]
- Disclosure Title: Setting of Record Date or Period for Closure of Shareholder Register
- Record Date: December 31, 2024
- Period for Closure of Shareholder Register (Suspension of Entry):
- Start Date: January 1, 2025
- End Date: January 31, 2025
- Reason for Setting: Determination of entitled shareholders for convening the 14th Annual General Meeting of Shareholders
- Other Important Details: Not applicable (-)
- Related Disclosure: Not applicable (-)
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Monitoring Shareholder Entitlement and Subsequent AGM Notices
This disclosure provides notice of the record date and closure period set to establish voting rights for the upcoming 14th AGM.
Following the record date setup (December 31, 2024), tracking subsequent official disclosures regarding the board decision to convene the AGM and proposed agenda details is essential.
Relevant developments can be verified in subsequent official disclosures and periodic filings.
📢 Disclaimer & Source Notice
Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s DART system.
Investment Risk Warning: This content is provided solely for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any security. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
